This inventor holds 1 USPTO granted patent. Top assignee: Nantcell, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jay Gardner Nelson and His Patent Work
Introduction
Jay Gardner Nelson is an inventor based in Sherman Oaks, California. His work includes a patent concerning peptide therapeutics targeting the SARS-CoV-2 spike protein.
Latest Patents
Nelson is associated with 1 patent: “Peptide Therapeutics Against SARS-COV-2 Spike Protein.” The patent focuses on peptide-based approaches related to the virus’s spike protein.
Career Highlights
Nelson is associated with NantCell, Inc. His listed patent reflects work in biotechnology and therapeutic innovation.
Collaborations
Nelson’s listed coworkers include Oleksandr Buzko and Wendy M. Higashide.
Conclusion
Jay Gardner Nelson’s patent work connects peptide therapeutics with research targeting the SARS-CoV-2 spike protein.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile